| Date Checked | 2026-06-19 21:51:47 |
|---|---|
| Graham Number | (PB)nan vs (PE)0.00 |
| Over / Under Value Percentage | 0.00% vs 0.00% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | ABSI |
| AssetType | Common Stock |
| Name | Absci Corp |
| Description | Absci Corp (ABSI) is a cutting-edge biotechnology company that utilizes an advanced AI-driven biology platform to revolutionize the drug discovery process. By facilitating the rapid generation of high-quality proteins and therapeutic candidates, Absci significantly shortens development timelines and lowers costs, making it a key player in the biopharmaceutical industry. The company actively collaborates with a diverse array of partners to create and manufacture next-generation therapies, underscoring its commitment to innovation and precision. With a robust pipeline of collaborations and proprietary programs, Absci is poised to deliver meaningful advancements in modern medicine and address critical healthcare challenges. |
| CIK | 1672688 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | BIOTECHNOLOGY |
| Address | 18105 SE MILL PLAIN BOULEVARD, VANCOUVER, WA, UNITED STATES, 98683 |
| OfficialSite | https://www.absci.com |
| FiscalYearEnd | December |
| LatestQuarter | 2026-03-31 |
| MarketCapitalization | 795116000 |
| EBITDA | -116437000 |
| PERatio | 0 |
| PEGRatio | None |
| BookValue | 1.107 |
| DividendPerShare | None |
| EPS | -0.82 |
| RevenuePerShareTTM | 0.013 |
| ProfitMargin | 0 |
| OperatingMarginTTM | -143.47 |
| ReturnOnAssetsTTM | -0.373 |
| ReturnOnEquityTTM | -0.639 |
| RevenueTTM | 1836000 |
| GrossProfitTTM | -81793000 |
| DilutedEPSTTM | -0.82 |
| QuarterlyEarningsGrowthYOY | 0 |
| QuarterlyRevenueGrowthYOY | -0.818 |
| AnalystTargetPrice | 8.76 |
| AnalystRatingStrongBuy | 2 |
| AnalystRatingBuy | 6 |
| AnalystRatingHold | 1 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | - |
| ForwardPE | - |
| PriceToSalesRatioTTM | 433.07 |
| PriceToBookRatio | 4.623 |
| EVToRevenue | 367.01 |
| EVToEBITDA | -0.391 |
| Beta | 2.376 |
| 52WeekHigh | 6.72 |
| 52WeekLow | 2.24 |
| 50DayMovingAverage | 3.974 |
| 200DayMovingAverage | 3.362 |
| SharesOutstanding | 155905000 |
| SharesFloat | 146164000 |
| PercentInsiders | 13.045 |
| PercentInstitutions | 78.848 |
| ExDividendDate | None |
| etoro | 1 |
| dateChecked | 2026-06-19 21:51:47 |
| fresh | 1 |